Statin Treatment in Children With Familial Hypercholesterolemia
Jessica Rodenburg(Amsterdam UMC Location Vrije Universiteit Amsterdam), Barbara A. Hutten(Amsterdam University Medical Centers), A S Paul van Trotsenburg(Emma Kinderziekenhuis), Frits A. Wijburg(Emma Kinderziekenhuis), Eric de Groot(Amsterdam UMC Location Vrije Universiteit Amsterdam), John J.P. Kastelein(QRx Pharma (United States)), Maud N. Vissers(Amsterdam UMC Location University of Amsterdam), Anouk van der Graaf(Amsterdam UMC Location Vrije Universiteit Amsterdam), Albert Wiegman(Amsterdam University Medical Centers)
Cited by 283
Related Papers
Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease
|New England Journal of Medicine|2017|9.1k
Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: Consensus Statement of the European Atherosclerosis Society
|European Heart Journal|2013|2.7k
American Society of Hematology 2020 Guidelines for Management of Venous Thromboembolism: Treatment of Deep Vein Thrombosis and Pulmonary Embolism
|Blood Advances|2020|1.4k
Effect of interleukin-1β inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomised, double-blind, placebo-controlled trial
|The Lancet|2017|1.3k
Simvastatin with or without Ezetimibe in Familial Hypercholesterolemia
|New England Journal of Medicine|2008|1.2k